Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2016 08:00 ET | Source: BioMark Diagnostics Inc.

BioMark Closes Second Tranche of Private Placement Offering

VANCOUVER, British Columbia, June 24, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that further to its...
June 20, 2016 08:00 ET | Source: BioMark Diagnostics Inc.

BioMark Engages Stockhouse.com Deal Room with Private Placement

VANCOUVER, British Columbia, June 20, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce it has engaged...
March 29, 2016 08:00 ET | Source: BioMark Diagnostics Inc.

BioMark Receives Approval for Its Lung Cancer Treatment Protocol

VANCOUVER, British Columbia, March 29, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that it has now...
March 15, 2016 08:00 ET | Source: BioMark Diagnostics Inc.

BioMark Closes First Tranche of Private Placement Offering

VANCOUVER, British Columbia, March 15, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that further to its...
March 09, 2016 16:45 ET | Source: BioMark Diagnostics Inc.

BioMark Announces Private Placement Offering

VANCOUVER, British Columbia, March 09, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce a non-brokered Private...
February 16, 2016 08:00 ET | Source: BioMark Diagnostics Inc.

BioMark Announces Progress Towards Data Analysis

VANCOUVER, British Columbia, Feb. 16, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces that BioMark has completed the internal standards for...
September 10, 2015 08:00 ET | Source: BioMark Diagnostics Inc.

BioMark Diagnostics to Conduct Validation Studies for Its Patented Assays in Patients With Lung Cancer

VANCOUVER, British Columbia, Sept. 10, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces that it expects to begin conducting studies in the...
September 09, 2015 08:00 ET | Source: BioMark Diagnostics Inc.

BioMark Diagnostics Receives Clearance From Health Canada to Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer

VANCOUVER, British Columbia, Sept. 9, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces receipt of a No Objection Letter from Health Canada,...
September 03, 2015 08:00 ET | Source: BioMark Diagnostics Inc.

BioMark Diagnostics to Present at Rodman & Renshaw Global Investment Conference

VANCOUVER, British Columbia, Sept. 3, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces that President and CEO Rashid Ahmed will present a...
September 03, 2015 08:00 ET | Source: BioMark Diagnostics Inc.

BioMark Diagnostics to Present at Rodman & Renshaw Global Investment Conference

VANCOUVER, British Columbia, Sept. 3, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces that President and CEO Rashid Ahmed will present a...